Sparsentan received full FDA approval for FSGS in patients aged 8–75 years, addressing a rare, progressive glomerulopathy ...

The mCRPC section's reorganization by prior treatment exposure reflects how ARPI and docetaxel use in the hormone-sensitive ...

As HIV care continues to evolve, 2-drug regimens are emerging as a key strategy to balance efficacy with long-term ...

Benjamin Lockshin, MD, FAAD, examines the non-clinical reasons driving real-world treatment discontinuation and explains how ...

Real-world persistence data for tildrakizumab paint an encouraging picture of long-term treatment durability, with ...

Bone-only, osteoblastic disease and the absence of prior ARPI exposure define the optimal radium-223 candidate, while ...

The forecasting model projects that without major intervention, 1.8 billion people will have MASLD by 2050, and a ...

Lalan Wilfong, MD, a medical oncologist well-known for his work in practice transformation, said he looks forward to creating "something more or less from scratch." Lalan Wilfong, MD, one of the ...

Although the vast majority of physicians using an artificial intelligence (AI) scribe perceived a reduction in documentation time, those with the most actual time savings had higher relative baseline ...

Looking into the future of alopecia areata will require a focus on the psychological aspects of the skin condition and the ...

Equity gaps in lung cancer molecular testing persist; reflex testing and nurse navigation speed care, while coverage and ...

Telemedicine utilization has declined since the peak of the COVID-19 pandemic, but non–primary care specialties continue to see an increase in moderate- and high-complexity telemedicine visits.